tiprankstipranks
Trending News
More News >
Advertisement

FLGB - ETF AI Analysis

Compare

Top Page

FLGB

Franklin FTSE United Kingdom ETF (FLGB)

Rating:73Outperform
Price Target:
FLGB, the Franklin FTSE United Kingdom ETF, has a solid overall rating driven by strong core holdings like HSBC and AstraZeneca, which benefit from robust financial performance, positive earnings calls, and supportive corporate actions. Rio Tinto and Barclays also add to the fund’s quality with healthy balance sheets, attractive valuations, and constructive technical trends. The main risk factor is the fund’s reliance on a relatively small group of large UK companies and sectors, so weakness in major names like Shell, Rolls-Royce, or Unilever—where technical or financial concerns are noted—could weigh on overall results.
Positive Factors
Low Expense Ratio
The fund charges a relatively low fee, which helps investors keep more of their returns over time.
Broad Sector Diversification Within the UK
Holdings spread across financials, consumer goods, industrials, health care, energy, and other sectors help reduce the impact of weakness in any single industry.
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Negative Factors
Heavy UK Concentration
Almost all assets are invested in UK companies, so the fund is highly sensitive to the health of the UK economy and market.
Top Holdings Concentration
A small number of large positions like HSBC, AstraZeneca, and Shell make up a significant share of the portfolio, increasing the impact if any of these stocks struggle.
Mixed Performance Among Key Stocks
Some major holdings such as AstraZeneca, Shell, Unilever, and GSK have shown weaker year-to-date performance, which can drag on overall fund returns even as others perform well.

FLGB vs. SPDR S&P 500 ETF (SPY)

FLGB Summary

The Franklin FTSE United Kingdom ETF (FLGB) tracks the FTSE UK RIC Capped Index, giving you broad exposure to the overall UK stock market in a single investment. It holds many well-known British companies such as HSBC Holdings and AstraZeneca, along with banks, consumer brands, energy firms, and industrial companies. Someone might consider this ETF to diversify outside their home country and to invest in the long-term growth of the UK economy without picking individual stocks. A key risk is that its value can rise or fall with the UK stock market and the health of the UK economy.
How much will it cost me?The Franklin FTSE United Kingdom ETF (FLGB) has an expense ratio of 0.09%, which means you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, keeping costs down.
What would affect this ETF?The Franklin FTSE United Kingdom ETF (FLGB) could benefit from positive trends in the UK economy, such as growth in the financial and healthcare sectors, which are heavily weighted in the fund. However, potential risks include economic uncertainty due to interest rate changes, energy price volatility affecting holdings like Shell and BP, and regulatory shifts impacting major industries like financials and consumer goods. Investors should also consider how broader European economic conditions might influence the ETF's performance.

FLGB Top 10 Holdings

This U.K.-only fund leans heavily on big banks and global blue chips, and lately the financial engines are doing most of the pulling. HSBC and Barclays have been rising, giving the ETF a solid lift, while Rolls-Royce has been a standout high-flyer in the mix. On the flip side, consumer giant Unilever is losing steam, and AstraZeneca has been more mixed, keeping a lid on gains from health care. Energy names like Shell and BP are mostly steady, adding ballast rather than big upside.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
HSBC Holdings9.09%$89.20M£220.77B51.99%
80
Outperform
AstraZeneca8.40%$82.40M£210.86B19.89%
80
Outperform
Shell (UK)6.65%$65.29M£158.23B4.31%
73
Outperform
Unilever4.36%$42.82M£107.74B-5.19%
72
Outperform
Rolls-Royce Holdings4.23%$41.50M£102.13B124.42%
71
Outperform
British American Tobacco3.84%$37.63M£94.95B36.88%
71
Outperform
GlaxoSmithKline3.09%$30.30M£75.70B33.56%
77
Outperform
BP p.l.c.3.00%$29.39M£71.35B9.78%
71
Outperform
Rio Tinto2.87%$28.17M£113.21B37.76%
82
Outperform
Barclays2.79%$27.34M£67.09B63.70%
78
Outperform

FLGB Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
33.51
Positive
100DMA
32.71
Positive
200DMA
31.25
Positive
Market Momentum
MACD
0.53
Negative
RSI
66.16
Neutral
STOCH
77.78
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FLGB, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 34.70, equal to the 50-day MA of 33.51, and equal to the 200-day MA of 31.25, indicating a bullish trend. The MACD of 0.53 indicates Negative momentum. The RSI at 66.16 is Neutral, neither overbought nor oversold. The STOCH value of 77.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FLGB.

FLGB Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$980.41M0.09%
$3.00B0.50%
$767.55M0.07%
$725.18M0.50%
$95.54M0.80%
$44.94M0.59%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FLGB
Franklin FTSE United Kingdom ETF
35.37
9.14
34.85%
EWU
iShares MSCI United Kingdom ETF
SPEU
SPDR Portfolio Europe ETF
EWI
iShares MSCI Italy ETF
FKU
First Trust United Kingdom AlphaDEX Fund
EWUS
iShares MSCI United Kingdom Small Cap ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement